Improved detection reveals active β-papillomavirus infection in skin lesions from kidney transplant recipients

Modern Pathology

Volumn 27, Issue 8, 2014, Pages 1101-1115

  Borgogna, Cinzia ^a   Lanfredini, Simone ^a   Peretti, Alberto ^a   De Andrea, Marco ^a,b   Zavattaro, Elisa ^a   Colombo, Enrico ^a   Quaglia, Marco ^a   Boldorini, Renzo ^a   Miglio, Umberto ^a   Doorbar, John ^c   Bavinck, Jan N Bouwes ^d   Quint, Koen D ^d,e   De Koning, Maurits Nc ^e   Landolfo, Santo ^b   Gariglio, Marisa ^a  

^a Azienda Ospedaliero Universitaria Maggiore della Carità   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e DDL DIAGNOSTIC LABORATORY   (Netherlands)

Author keywords

HPV; immunosuppression; kidney transplant recipients; skin cancer; viral life cycle;

Indexed keywords

CAPSID PROTEIN L1; MINICHROMOSOME MAINTENANCE PROTEIN 7; VIRUS ANTIBODY; VIRUS DNA; VIRUS PROTEIN; CAPSID PROTEIN; HPV L1 PROTEIN, HUMAN PAPILLOMAVIRUS; MCM7 PROTEIN, HUMAN; ONCOPROTEIN; TUMOR MARKER;

ACTINIC KERATOSIS; ANTIGEN EXPRESSION; ARTICLE; BASAL CELL CARCINOMA; BETAPAPILLOMAVIRUS; BOWEN DISEASE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; FOLLOW UP; GENOTYPE; GRAFT RECIPIENT; HISTOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 24; HUMAN TISSUE; KERATOACANTHOMA; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEBORRHEIC KERATOSIS; SKIN DEFECT; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; TISSUE SECTION; VIRUS DETECTION; VIRUS GENOME; VIRUS REPLICATION; ADVERSE EFFECTS; AGED; CHEMISTRY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN PAPILLOMAVIRUS DNA TEST; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; ITALY; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; RISK FACTOR; SKIN TUMOR; UNIVERSITY HOSPITAL; VIROLOGY;

AGED; BETAPAPILLOMAVIRUS; CAPSID PROTEINS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; HOSPITALS, UNIVERSITY; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; IMMUNOHISTOCHEMISTRY; ITALY; KERATOSIS, ACTINIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 7; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VIRUS REPLICATION;

EID: 84905449992     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.240     Document Type: Article

References (60)

1. Tessari G, Naldi L, Boschiero L, et al. Incidence of primary and second cancers in renal transplant recipients: a multicenter cohort study. Am J Transplant 2013; 13:214-221.
2. Stratta P, Morellini V, Musetti C, et al. Malignancy after kidney transplantation: results of 400 patients from a single center. Clin Transplant 2008;22:424-427.
3. Hall EC, Pfeiffer RM, Segev DL, et al. Cumulative incidence of cancer after solid organ transplantation. Cancer 2013;119:2300-2308.
4. Piselli P, Serraino D, Segoloni GP, et al. Immunosuppression and Cancer Study Group. Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009. Eur J Cancer 2013;49:336-344.
5. Piselli P, Busnach G, Fratino L, et al. De novo malignancies after organ transplantation: focus on viral infections. Curr Mol Med 2013;13:1217-1227.
6. Schulz TF. Cancer and viral infections in immunocompromised individuals. Int J Cancer 2009;125:1755-1763.
7. Piselli P, Busnach G, Citterio F, et al. Risk of Kaposi sarcoma after solid-organ transplantation: multicenter study in 4,767 recipients in Italy, 1970-2006. Transplant Proc 2009;41:1227-1230.
8. Grulich AE, van Leeuwen MT, Falster MO, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007;370:59-67.
9. THE SCOPE Collaborative Group Skin Cancer After Organ Transplantation. Springer: Berlin, 2009;502 pp.
10. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003;348:1681-1691.
11. Villeneuve PJ, Schaubel DE, Fenton SS, et al. Cancer incidence among Canadian kidney transplant recipients. Am J Transplant 2007;7:941-948.
12. Wisgerhof HC, Edelbroek JRJ, de Fijter JW, et al. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors. Transplantation 2010;89:1231-1238.
13. Wisgerhof HC, van der Geest LGM, de Fijter JW, et al. Incidence of cancer in kidney-transplant recipients: a long-term cohort study in a single center. Cancer Epidemiol 2011;35:105-111.
14. Kovach BT, Stasko T. Skin cancer after transplantation. Transplant Rev 2009;23:178-189.
15. Jensen AØ, Lamberg AL, Jacobsen JB, et al. Nonmelanoma skin cancer and ten-year all-cause mortality: a population-based cohort study. Acta Dermatol Venereol 2010;90:362-367.
16. Buell JF, Hanaway MJ, Thomas M, et al. Skin cancer following transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc 2005;37:962-963.
17. Hofbauer GFL, Bouwes Bavinck JN, Euvrard S. Organ transplantation and skin cancer: basic problems and new perspectives. Exp Dermatol 2010; 19:473-482.
18. Rüegg CP, Graf N, Mühleisen B, et al. Squamous cell carcinoma of the skin induces considerable sustained cost of care in organ transplant recipients. J Am Acad Dermatol 2012;67:1242-1249.
19. De Koning MNC, Struijk L, Bavinck JNB, et al. Betapapillomaviruses frequently persist in the skin of healthy individuals. J Gen Virol 2007;88:1489-1495.
20. Foulongne V, Sauvage V, Hebert C, et al. Human skin microbiota: high diversity of DNAviruses identified on the human skin by high throughput sequencing. PLoS One 2012;7:e38499.
21. Nindl I, Rö sl F. Molecular concepts of virus infections causing skin cancer in organ transplant recipients. Am J Transplant 2008;8:2199-2204.
22. Bouwes Bavinck JN, Neale RE, Abeni D, et al. Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. Cancer Res 2010;70:9777-9786.
23. Doorbar J, Quint W, Banks L, et al. The biology and life-cycle of human papillomaviruses. Vaccine 2012;30(Suppl 5):F55-F70.
24. Akgül B, Cooke JC, Storey A. HPV-associated skin disease. J Pathol 2006;208:165-175.
25. Arron ST, Jennings L, Nindl I, et al. Viral oncogenesis and its role in nonmelanoma skin cancer. Br J Dermatol 2011;164:1201-1213.
26. De Villiers E-M. Cross-roads in the classification of papillomaviruses. Virology 2013;445:2-10.
27. Bernard H-U. Taxonomy and phylogeny of papillomaviruses: an overview and recent developments. Infect Genet Evol 2013;18:357-361.
28. McLaughlin-Drubin ME, Meyers J, Munger K. Cancer associated human papillomaviruses. Curr Opin Virol 2012;2:459-466.
29. Bravo IG, de Sanjosé S, Gottschling M. The clinical importance of understanding the evolution of papillomaviruses. Trends Microbiol 2010;18:432-438.
30. Lazarczyk M, Cassonnet P, Pons C, et al. The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. Microbiol Mol Biol Rev 2009;73: 348-370.
31. Lazarczyk M, Pons C, Mendoza J-A, et al. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med 2008;205:35-42.
32. Nindl I, Gottschling M, Stockfleth E. Human papillomaviruses and non-melanoma skin cancer: basic virology and clinical manifestations. Dis Markers 2007;23: 247-259.
33. Borgogna C, Zavattaro E, De Andrea M, et al. Characterization of beta papillomavirus E4 expression in tumours from epidermodysplasia verruciformis patients and in experimental models. Virology 2012; 423:195-204.
34. Dell'Oste V, Azzimonti B, De Andrea M, et al. High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. J Invest Dermatol 2009;129:1026-1034.
35. Neale RE, Weissenborn S, Abeni D, et al. Human papillomavirus load in eyebrow hair follicles and risk of cutaneous squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2013;22:719-727.
36. Proby CM, Harwood CA, Neale RE, et al. A case- control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant 2011;11:1498-1508.
37. Madeleine MM, Johnson LG, Daling JR, et al. Cohort profile: the skin cancer after organ transplant study. Int J Epidemiol 2012;doi:10.1093/ije/dys179 (e-pub ahead of print).
38. Tessari G, Girolomoni G. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management. Dermatol Surg 2012;38:1622-1630.
39. Mackintosh LJ, de Koning MNC, Quint WGV, et al. Presence of beta human papillomaviruses in nonmelanoma skin cancer from organ transplant recipients and immunocompetent patients in the West of Scotland. Br J Dermatol 2009;161:56-62.
40. Farzan SF, Waterboer T, Gui J, et al. Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a populationbased study. Int J Cancer 2013;133:1713-1720.
41. Karagas MR, Waterboer T, Li Z, et al. Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study. BMJ 2010;341:c2986
42. Plasmeijer EI, Neale RE, de Koning MNC, et al. Persistence of betapapillomavirus infections as a risk factor for actinic keratoses, precursor to cutaneous squamous cell carcinoma. Cancer Res 2009;69: 8926-8931.
43. Antonsson A, Waterboer T, Bouwes Bavinck JN, et al. Longitudinal study of seroprevalence and serostability of 34 human papillomavirus types in European organ transplant recipients. Virology 2013;436:91-99.
44. Purdie KJ, Surentheran T, Sterling JC, et al. Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J Invest Dermatol 2005;125:98-107.
45. Griffin H, Wu Z, Marnane R, et al. E4 antibodies facilitate detection and type-assignment of active HPV infection in cervical disease. PLoS One 2012;7: e49974.
46. Schaper ID, Marcuzzi GP, Weissenborn SJ, et al. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res 2005;65:1394-1400.
47. De Andrea M, Rittà M, Landini MM, et al. Keratinocyte-specific stat3 heterozygosity impairs development of skin tumors in human papillomavirus 8 transgenic mice. Cancer Res 2010;70: 7938-7948.
48. De Koning M, Quint W, Struijk L, et al. Evaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridization assay for detection and identification of beta-papillomavirus DNA. J Clin Microbiol 2006;44: 1792-1800.
49. Peh WL, Doorbar J. Detection of papillomavirus proteins and DNA in paraffin-embedded tissue sections. Methods Mol Med 2005;119:49-59.
50. Doorbar J. The papillomavirus life cycle. J Clin Virol 2005;32(Suppl 1):S7-S15.
51. Doorbar J. Papillomavirus life cycle organization and biomarker selection. Dis Markers 2007;23: 297-313.
52. Ko CJ, Iftner T, Barr RJ, et al. Changes of epidermodysplasia verruciformis in benign skin lesions: the EV acanthoma. J Cutan Pathol 2007;34:44-48.
53. Leiding JW, Holland SM. Warts and all: human papillomavirus in primary immunodeficiencies. J Allergy Clin Immunol 2012;130:1030-1048.
54. Feltkamp MCW, de Koning MNC, Bavinck JNB, et al. Betapapillomaviruses: innocent bystanders or causes of skin cancer. J Clin Virol 2008;43:353-360.
55. Weissenborn SJ, Nindl I, Purdie K, et al. Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 2005;125:93-97.
56. Ganzenmueller T, Yakushko Y, Kluba J, et al. Nextgeneration sequencing fails to identify human virus sequences in cutaneous squamous cell carcinoma. Int J Cancer J Int Cancer 2012;131:E1173-E1179.
57. Arron ST, Ruby JG, Dybbro E, et al. Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma. J Invest Dermatol 2011;131:1745-1753.
58. Wallace NA, Robinson K, Howie HL, et al. HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage. PLoS Pathogen 2012;8:e1002807.
59. Pfister H. Chapter 8. Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003;52-56.
60. Schiller JT, Buck CB. Cutaneous squamous cell carcinoma: a smoking gun but still no suspects. J Invest Dermatol 2011;131:1595-1596.